Search Results

PND34 - Treatment with interferon beta-1a in brazil is associated with fewer hospitalizations due to relapse, better adherence and a better response compared to other platform therapies.

• Authors : Serafini, P¹; Pike, J²; Jones, E²

Subjects: *INTERFERON beta 1b; *DISEASE relapse; *PATIENT complianceBRAZIL

• Source: Value in Health. May2016, Vol. 19 Issue 3, pA64-A65. 1p.

Record details

Lovastatin producing by wild strain of Aspergillus terreus isolated from Brazil.

• Authors : Oliveira, Marcella Cardoso Lemos de; Paulo, Anderson José; Lima, Carolina de Albuquerque

Subjects: ASPERGILLUS terreus; LOVASTATIN; SOY flourBRAZIL

• Source: Preparative Biochemistry & Biotechnology; 2021, Vol. 51 Issue 2, p164-172, 9p

Record details

Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study.

• Authors : Souza, Kathiaja Miranda; Diniz, Isabela Maia; Lemos, Lívia Lovato Pires de

Subjects: PROPENSITY score matching; NATALIZUMAB; MULTIPLE sclerosisBRAZIL

• Source: PLoS ONE; 9/2/2020, Vol. 15 Issue 9, p1-16, 16p

Record details

The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil.

• Authors : Lemos, Livia Lovato Pires de; Guerra Júnior, Augusto Afonso; Santos, Marisa

Subjects: INTERFERON beta-1a; MULTIPLE sclerosis; DISINVESTMENTBRAZIL

• Source: PharmacoEconomics; Feb2018, Vol. 36 Issue 2, p161-173, 13p

Record details

Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.

• Authors : Lopes da Silva, Nilceia; Takemoto, Maira L. S.; Damasceno, Alfredo

Subjects: MULTIPLE sclerosis; PUBLIC health; MEDICAL care costsBRAZIL

• Source: BMC Health Services Research; 3/24/2016, Vol. 16, p1-12, 12p, 3 Charts, 2 Graphs

Record details

Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study.

• Authors : Quispe-Cabanillas, Juan G.; Damasceno, Alfredo; von Glehn, Felipe

Subjects: IMMUNOLOGICAL adjuvants; MULTIPLE sclerosis treatment; ANALYSIS of varianceBRAZIL

• Source: BMC Complementary & Alternative Medicine; 2012, Vol. 12 Issue 1, p209-215, 7p, 1 Diagram, 1 Chart, 5 Graphs

Record details

EE376 Estimated Financial Impact of the Drug Cladribine Incorporation for the Relapsing-Remitting Multiple Sclerosis Treatment (RRMS) in a Health Insurance Company in Brazil.

• Authors : Alves Junior, J.M.¹ (AUTHOR); Prota, F.E.¹ (AUTHOR); Martinelli, J.C.B.¹ (AUTHOR)

Subjects: *HEALTH insurance companies; *MULTIPLE sclerosis; *DISEASE relapseBRAZIL

• Source: Value in Health. 2023 Supplement, Vol. 26 Issue 6, pS128-S128. 1p.

Record details

Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review.

• Authors : Lucchetta, Rosa C.; Leonart, Letícia P.; Gonçalves, Marcus V. M.

• Source: PLoS ONE. June 16, 2020, Vol. 15 Issue 6, e0231722.

Record details

Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach.

• Authors : Julian, Guilherme Silva; Rosim, Ricardo Papaléo; Carneseca, Estela Cristina

• Source: PLoS ONE. March 2, 2020, Vol. 15 Issue 3, e0229768.

Record details

Immunomodulatory treatment in multiple sclerosis: experience at a Brazilian center with 390 patients.

• Authors : Tilbery CP; Central of Attendance of Multiple Sclerosis Treatment, Santa Casa of São Paulo, Brazil. ; Mendes MF

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*therapeutic use ; Interferon-beta/Interferon-beta/Interferon-beta/*therapeutic use ; Multiple Sclerosis/Multiple Sclerosis/Multiple Sclerosis/*drug therapy

• Source: Arquivos de neuro-psiquiatria [Arq Neuropsiquiatr] 2006 Mar; Vol. 64 (1), pp. 51-4. Date of Electronic Publication: 2006 Apr 05.Publisher: Thieme Country of Publication: Germany NLM ID: 0125444 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0004-282X (Print)

Record details